Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 167   

Articles published

GSK 1,467.00 -25.50 (-1.71%)
price chart
3 Neil Woodford High-Yield Shares For 2015: GlaxoSmithKline plc, Imperial ...
Are you looking for outstanding dividend picks for 2015? Look no further than the top yielders among the biggest blue-chip holdings of renowned fund manager Neil Woodford.
Related articles »  
5 Stunning Pharma Stocks: GlaxoSmithKline plc, AstraZeneca plc, Shire PLC ...
Investor sentiment in GlaxoSmithKline (LSE: GSK) has stabilised in recent months, with shares in the company beating the FTSE 100's performance by 2% over the last three months.
GlaxoSmithKline plc (LSE/NYSE: GSK) has today received clearance from the European Commission of its proposed three-part transaction with Novartis which includes the acquisition of Novartis's vaccines business (excluding influenza vaccines), the ...
What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Inmarsat ...
Merchants Trust (LSE: MRCH) has delivered 32 consecutive years of dividend increases, and carries a trailing yield of 5.1% at a current share price of 463p.
GlaxoSmithKline plc Stock Rating Reaffirmed by JPMorgan Chase & Co. (GSK)
GSK has been the subject of a number of other recent research reports. Analysts at Berenberg Bank raised their price target on shares of GlaxoSmithKline plc from GBX 1,540 ($23.11) to GBX 1,620 ($24.31) and gave the company a �hold� rating in a ...
GlaxoSmithKline plc Given "Underweight" Rating at JPMorgan Chase ...  Dakota Financial News
GlaxoSmithKline plc Given Underweight Rating at JPMorgan Chase & Co. (GSK)  WKRB News
GlaxoSmithKline plc's "Underweight" Rating Reiterated at JPMorgan Chase ...
GlaxoSmithKline plc (NYSE:GSK)'s stock had its �underweight� rating restated by analysts at JPMorgan Chase & Co.
Morningstar Gives A+ Credit Rating to GlaxoSmithKline plc (GSK)  WKRB News
GlaxoSmithKline plc Price Target Increased to GBX 1620 by Analysts at ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) had its price target increased by Berenberg Bank from GBX 1,540 ($23.31) to GBX 1,620 ($24.52) in a research report sent to investors on Friday morning.
GlaxoSmithKline plc 4Q 2014 -- Forecast
FRANKFURT--The following is a summary of analysts' forecasts for GlaxoSmithKline plc (GSK) fourth-quarter results, based on a poll of 12 analysts conducted by Dow Jones Newswires (figures in million pound, EPS, dividend and target price in pence, ...
Company News: GlaxoSmithKline plc (ADR) (NYSE:GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK) announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US.
GlaxoSmithKline plc Receives $50.67 Consensus Price Target from Brokerages ...  sleekmoney
Brokerages Set GlaxoSmithKline plc PT at $50.67 (NYSE:GSK)  Mideast Time
GlaxoSmithKline plc's Underweight Rating Reiterated at JPMorgan Chase & Co ...
GlaxoSmithKline plc (ADR) logo JPMorgan Chase & Co. reaffirmed their underweight rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a report issued on Tuesday. JPMorgan Chase & Co. has also taken action a number of other healthcare stocks ...
GlaxoSmithKline plc Rating Reiterated by BNP Paribas (GSK)  sleekmoney
New Street Research Rating Disclosure on GlaxoSmithKline plc (ADR)  Stafford Daily